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Abstract 
Objective: Reperfusion of ischemic myocardium generates oxidative stress, which itself can mediate myocardial 
injury. So, in this study, we investigated the level of oxidative stress markers and its association with clinical outcomes 
in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary 
intervention.
Results: As indicated in the results, Post MI (Myocardial Infarction) heart failure was significantly higher in the group 
A (11% vs 4%, p = 0.047). Complete STR (ST-segment resolution) was observed to be significantly higher in the group 
B (36% vs 17%, p = 0.006). The SOD (Superoxide dismutase) and GPX (Glutathione peroxidase) levels were signifi-
cantly higher in the group B compared to the other group (1547.51 ± 328.29 vs. 1449.97 ± 246.06, p = 0.019 and 
60.62 ± 11.95 vs 57.41 ± 10.14, p = 0.042). The levels of GPX and SOD were shown to be directly related with complete 
STR and post PCI (Percutaneous coronary intervention)TIMI(Thrombolysis in Myocardial Infarction) flow 3 in the group 
A (p = 0.002 and p < 0.01, p = 0.005 and p < 0.02, respectively).
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Introduction
Cardiovascular disease is known as the leading cause of 
death worldwide [1].  Cardiovascular risk factors result 
in endothelial injury and propagate  atherosclerosis [2]. 
Accordingly, acute myocardial infarction (MI) is one 
of the most prevalent forms of ischemic heart diseases 
[3]. The most important decision for a patient with ST-
segment elevation myocardial infarction (STEMI) is the 
early and successful myocardial reperfusion by the use 
of thrombolytic therapy or primary percutaneous coro-
nary intervention (PPCI), which has been shown as effec-
tive method on balancing the blood supply as well as 
demanding and improving the clinical outcome [4–6].
Various studies have indicated that, huge quanti-
ties of reactive oxygen species (ROS) are produced 
during reperfusion of the blood flow after MI [7, 8]. 
Consequently, these highly reactive species cause oxi-
dative damage [9], which thereby lead to myocardial 
ischemia–reperfusion injury that can paradoxically 
reduce the beneficial effects of myocardial reperfusion 
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product, is known as one of the oxidative stress bio-
markers [12, 13]. Beyond that superoxide dismutase 
(SOD) and glutathione peroxidase (GPX) are the first 
well- known line enzymes of the antioxidant defense 
[14, 15]. Correspondingly, some studies have shown 
the role of oxidant-antioxidant imbalance in the patho-
genesis of myocardial ischemia and reperfusion injury. 
Moreover, antioxidant protects the cellular and sub-
cellular membranes against the oxidative stress injury. 
It was indicated that the increased activity of total anti-
oxidant capacity reduces the damages produced by the 
enhancement of lipid peroxidation, which may act by 
counteracting the harmful products [16, 17].
Thrombolysis in myocardial infarction (TIMI) flow 
is considered as the most valuable indicator of the epi 
cardial coronary flow. However, electrocardiographic 
ST resolution is a valuable marker of the improved 
myocardial reperfusion in microvascular system and 
also at the cellular level [18].
In this study, we investigated the probable role of 
stress oxidative markers (MDA, SOD, GPX, and Total 
antioxidant capacity (TAC)) among STEMI patients 
undergoing primary PCI based on Coronary TIMI flow, 
as well as their associations with in-hospital outcome. 
Therefore, in this study, we aimed to investigate the lev-
els of MDA, SOD, GPX, and Total antioxidant capacity 
(TAC) as well as their relationships with ST resolution 
and clinical outcomes among STEMI patients undergo-




This cross-sectional study was conducted in 2018on 
patients with STEMI in the first 6 h after their admission 
in the cardiology department at Madani Hospital, Tabriz, 
Iran.
The inclusion criteria were having resting chest pain for 
more than 20 min, showing variations in ECG with ST-
segment elevations greater than 2 mm in precordial leads 
and greater than 1 mm in limb leads, and having serum 
troponin or CK-MB levels at least two-fold of the upper 
limit of normal range regarding the laboratory references.
The exclusion criteria were also as follows: having Left 
Bundle Branch Block, late presentation (> 6  h), using 
pace-maker, having the history of Heart failure or rescue 
PCI, chronic disease, malignancy, and being a candidate 
for emergency Coronary Artery Bypass Graft. Among 
the patients scheduled for primary PCI after matching 
with the study protocol, the first 100 consecutive patients 
with TIMI flow < 2 were enrolled in the group A and 
the first 100 patients with TIMI flow ≥ 2 were enrolled 
in the group B (Fig. 1). The written consent as well as a 
complete physical examination were obtained from the 
included patients. Electrocardiograms were recorded 
once on arrival and once 90  min after Primary PCI. 
STR (ST-segment resolution) was measured by passing 
90 min from primary angioplasty at the same way to the 
maximal ST elevation in pre-angioplasty electrocardio-
gram. Mortality, arrhythmias, and post MI heart failure 
Fig. 1 The flow diagram of the study and patients allocations in groups
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were investigated as hospital outcomes. Those patients 
with a Left ventricular ejection fraction (LVEF) < 40% at 
the time of discharge and rales in the lungs auscultation 
or congestion in Chest X-Ray (in terms of the Ameri-
can Heart Association guideline) [19] were considered 
as patients with heart failure. This study was ethically 
approved in the Research Department of Tabriz Univer-
sity of Medical Sciences (Iran) under the code of 60,109.
Biochemical information
After an overnight fasting of 12  h, five mL of venous 
blood samples were taken from each one of the par-
ticipants. The obtained samples were centrifuged for 
10 min at 1500 rpm to separate the serum and then kept 
at − 80  °C for MDA, SOD, GPX, and TAC tests. After-
ward, RASOD kit (Randox, lab.crumlin.UK) and RAN-
SEL kits (Randox, lab.crumlin.UK) were used for the 
assessment of SOD, GPX, TAC, and MDA levels [20].
Data analysis and statistical methods
The distribution of the data was checked using Kol-
mogorov- Smirnov test. The independent sample t-test 
was also used for comparing these two groups. There-
after, Pearson coefficient correlation was used to evalu-
ate the relationships among SOD, GPX, levels and the 
rate of ST-R. The results were then reported in the form 
of mean ± standard deviation. In this regard, IBM SPSS 
Statistics (ver.23) was applied to analyze all the obtained 
data. The significance level was considered as 0.05 for all 
of the tests.
Results
In this study, 200 STEMI patients were investigated. 
Accordingly, no significant differences were found 
between these two groups regarding demographic and 
risk factors variables (Table 1).
Moreover, there was no significant difference between 
the two groups regarding serum levels of MDA and TAC. 
However, SOD and GPX levels were also observed to be 
significantly higher in the group B as compared to the 
group A (Table 2).
ST segment resolution was divided into three cat-
egories as follows: I. no response to treatment (ST-R 
levels < 50%), II. partial response to the treatment 
(50% ≤ ST-R levels < 70%), and III. complete response to 
the treatment (ST-R levels ≥ 70%) [21]. By investigating 
the relationship among SOD and GPX levels and the rate 
of ST-R, it was revealed that in the group A, both of the 
variables were associated with the rate of ST-R, while in 
group B, only the level of GPX was related to the rate of 
ST- resolution (Additional file 1: Table S1).
These two groups were not significantly different in 
terms of death and arrhythmia. However, the difference 
between these two groups was turned out to be signifi-
cant in terms of heart failure. The rate of complete ST-R 
was higher in the group B compared to that of the other 
group, which showed a significant difference between 
them. In addition, we observed a higher rate of TIMI 
3 flow after PCI in the group B compared to group A 
(Additional file 1: Table S2).
Discussion
The principal findings of this study were the higher level 
of SOD and GPX in patients with TIMI flow ≥ 2. Beyond 
that Post MI heart failure was significantly higher in 
patients with TIMI flow < 2. The higher level of complete 
Table 1 Comparison of  demographic and  baseline 
information and risk factors of CAD of Groups
NS, not significant, Group A: TIMI flow < 2, Group B: TIMI flow ≥ 2






Age, years 60.01 ± 12.3 61.55 ± 11.32 p > 0.05 (NS)
Gender, male 
n (%)
80 (70) 73 (73) p > 0.05 (NS)
Hypertension, 
n (%)
62 (62) 51 (51) p > 0.05 (NS)
Diabetes mellitus, 
n (%)
33 (33) 24 (24) p > 0.05 (NS)
Hyperlipidemia, 
n (%)
54 (54) 43 (43) p > 0.05 (NS)
Smoking, n (%) 35 (35) 33 (33) p > 0.05 (NS)
Family history, 
n (%)
32 (32) 27 (27) p > 0.05 (NS)
Anterior STEMI, 
n (%)
61 (61) 56 (56) p > 0.05 (NS)
Lateral STEMI, 
n (%)
5 (5) 6 (6) p > 0.05 (NS)
Inferior RV STEMI, 
n (%)
9 (9) 15 (15) p > 0.05 (NS)
Inferior STEMI, 
n (%)
25 (25) 23 (23) p > 0.05 (NS)
Table 2 The average serum levels of  biochemical factors 
in group A and B (mean ± SD)
SD: standard deviation, SOD: superoxide dismutase, GPX: Glutathione 
Peroxidase, MDA: Malondialdehyde, TAC: Total anti-oxidant capacity
*p < 0.05 in based on independent samples t-test between two groups Group A: 
TIMI flow < 2, Group B: TIMI flow ≥ 2
Variable Group A (n = 100) Group B (n = 100) p-value
MDA (nmol/ml) 2.33 ± 0.76 2.22 ± 0.82 0.133
TAC (mmol/l) 1.73 ± 0.4 1.65 ± 0.4 0.322
SOD (µ/g Hb) 1449.97 ± 246.06 1547.51 ± 328.29 0.019*
GPX (µ/g Hb) 57.41 ± 10.14 60.62 ± 11.95 0.042*
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STR in patients with TIMI flow ≥ 2 was other finding of 
this study.
The disruption in the blood flow and endothelial dys-
function, caused by the changes in the ion channels and 
the increased level of oxidative stress, may consequently 
lead to the formation of plaques in the coronary arter-
ies [22]. In this regard, reactive oxygen species are con-
sidered as the main initiators of myocardial damages 
during reperfusion process [14]. Two of the antioxidant 
enzymes, named SOD and GPX play important roles in 
supporting and protecting cells against oxidative dam-
ages [23, 24]. Previous studies have indicated that in those 
patients with occluded arteries, due to the generation of 
reactive oxygen species that is the result of inflammations 
induced by tissue damages, primary PCI causes more 
damages [15]. Our study indicated that the serum levels 
of oxidative markers are significantly related to the sever-
ity of myocardial infarction and myocardial dysfunction. 
This finding is consistent with the findings of some pre-
vious studies [25, 26]. Furthermore, in this study, it was 
found that, the incidence rate of ventricular dysfunction 
was lower in the group with TIMI ≥ 2 compared to the 
other group. The main reason of this result might be the 
higher levels of endogenous antioxidant enzymes like 
SOD and GPX, which protect the heart against reperfu-
sion-induced damages [25, 27].However, in our study, the 
two patients’ groups were not found to be significantly 
different in terms of the incidence of some complications 
such as arrhythmia and mortality.
One of the criteria that is considered in determining 
the level of response to treatment and the restoration of 
blood flow is ST-segment resolution [28]. Moreover, ST-
segment resolution is a simple sign of myocardial reper-
fusion, which has been shown to be associated with left 
ventricular function recovery as well as mortality [14, 29]. 
In this regard, various studies have demonstrated that if 
ST-segment does not return to its normal condition up to 
90 min after PCI, so it can be considered as a unfavora-
ble prognosis [26, 30, 31]. Researchers in various stud-
ies have asserted that the lack of ST-segment resolution 
is the indicator of a perfusion defect in the myocardial 
tissue [29]. Our study have also indicated that the rate 
of complete ST-segment resolution to the baseline was 
lower in the patients of the TIMI < 2 group (STR ≥ 70%) 
compared to the patients in the TIMI ≥ 2 group, which 
can be explained by the induced myocardial dysfunction 
resulted from the generation of more free radicals [20].
In a previous study, Kammler et al. reported that, after 
PCI, the patients with TIMI flow of equal to 2 or less than 
2 showed some adverse clinical complications during 
their hospitalization period as well as after 6-month fol-
low-up from the time being discharged from the hospital 
[25]. Other studies have also indicated that the decreased 
blood supply by the coronary arteries after primary PCI 
is accompanied with adverse clinical outcomes [27, 32]. 
However, it should also be noted that some other factors 
such as age, clinical manifestations, comorbidities, and 
the location of myocardial infarction play critical roles 
in the final outcome of STEMI patients, as candidates for 
primary PCI [29, 31].
In the present study, lipid peroxidation was evalu-
ated by measuring MDA level. In addition, the antioxi-
dant activity was also assessed via measuring TAC [23]. 
No significant differences were observed between these 
two study groups in terms of their MDA and TAC lev-
els. However, this issue requires further assessments in 
future studies.
In a study, it was observed that following Remote 
Ischemic Post Conditioning (RIPC) during primary PCI, 
the level of antioxidants has significantly increased, while 
the level of MDA has significantly decreased compared 
to the control group. Accordingly, these findings revealed 
the beneficial effects of RIPC on decreasing the reperfu-
sion-induced damages [20].
The analysis of various studies revealed the fact that 
the relationships among the oxidative stress, antioxidant 
markers, and myocardial infarction are mixed. Moreo-
ver, some studies have indicated that high levels of these 
markers in patients are associated with myocardial 
infarction, while some others have rejected the existence 
of such associations [25, 28, 33]. Correspondingly, this 
might be due to the fact that the levels of oxidative stress 
markers depend on various factors such as the duration 
of the appearance of symptoms and comorbidities like 
diabetes, as well as the other chronic diseases [20, 23]. 
On the other hand, these biomarkers may be simply con-
sidered as a marker of severe injury, so performing fur-
ther studies by matching their levels with the enzymatic 
infarct size or cardiac MR findings may be helpful to test 
this hypothesis.
Conclusion
The findings of this study indicated that antioxidant 
enzymes levels in patients with STEMI are significantly 
associated with coronary artery stenosis and the level of 
responses to treatment. However, such relationships were 
not observed regarding the TAC and MDA levels. The 
imbalance between the production of free radicals and 
antioxidant defense systems was shown to be strongly 
associated with cardiovascular disease and its unfortu-
nate outcome.
Limitations
Considering the limitations of the present study in 
measuring the levels of all antioxidant substances (sele-
nium, vitamin C, etc.), it seems that performing further 
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studies is necessary. Future studies with large sample 
size and by parallel measuring the levels of other anti-
oxidant substances and some inflammatory factors like 
hs-CRP, might be helpful for having more definitive 
conclusions.
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